DiaMedica Therapeutics (DMAC) Operating Margin (2018)

Historic Operating Margin for DiaMedica Therapeutics (DMAC) over the last 1 years, with Q3 2018 value amounting to 297.4%.

  • DiaMedica Therapeutics' Operating Margin changed N/A to 297.4% in Q3 2018 from the same period last year, while for Jun 2019 it was 1953.2%, marking a year-over-year change of. This contributed to the annual value of 78473.53% for FY2024, which is 181946500.0% down from last year.
  • According to the latest figures from Q3 2018, DiaMedica Therapeutics' Operating Margin is 297.4%.
  • DiaMedica Therapeutics' 5-year Operating Margin high stood at 297.4% for Q3 2018, and its period low was 297.4% during Q3 2018.